Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian marine-derived Streptomyces sp.

Zeinab G. Khalil; Ritesh Raju; Andrew M. Piggott; Angela A. Salim; Antje Blumenthal; Robert J. Capon

doi:10.1021/acs.jnatprod.5b00095

Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian marine-derived Streptomyces sp.

Zeinab G. Khalil, Ritesh Raju, Andrew M. Piggott, Angela A. Salim, Antje Blumenthal, Robert J. Capon

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Abstract

Chemical analysis of an Australian marine-derived Streptomyces sp. (CMB-M0150) yielded two new anthracycline antibiotics, aranciamycins I (1) and J (2), as well as the previously reported aranciamycin A (3) and aranciamycin (4). The aranciamycins 1-4, identified by detailed spectroscopic analysis, were noncytotoxic when tested against selected Gram-negative bacteria and fungi (IC50 >30 μM) and exhibited moderate and selective cytotoxicity against Gram-positive bacteria (IC50 >1.1 μM) and a panel of human cancer cell lines (IC50 > 7.5 μM). Significantly, 1-4 were cytotoxic (IC50 0.7-1.7 μM) against the Mycobacterium tuberculosis surrogate M. bovis bacille Calmette-GuÃ©rin.

Original language	English
Pages (from-to)	949-952
Number of pages	4
Journal	Journal of Natural Products
Volume	78
Issue number	4
DOIs	https://doi.org/10.1021/acs.jnatprod.5b00095
Publication status	Published - 2015

Keywords

infectious diseases
mycobacteria
tuberculosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/acs.jnatprod.5b00095

Cite this

@article{afc5e19a0fed46269d75b7a7551415c9,

title = "Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian marine-derived Streptomyces sp.",

abstract = "Chemical analysis of an Australian marine-derived Streptomyces sp. (CMB-M0150) yielded two new anthracycline antibiotics, aranciamycins I (1) and J (2), as well as the previously reported aranciamycin A (3) and aranciamycin (4). The aranciamycins 1-4, identified by detailed spectroscopic analysis, were noncytotoxic when tested against selected Gram-negative bacteria and fungi (IC50 >30 μM) and exhibited moderate and selective cytotoxicity against Gram-positive bacteria (IC50 >1.1 μM) and a panel of human cancer cell lines (IC50 > 7.5 μM). Significantly, 1-4 were cytotoxic (IC50 0.7-1.7 μM) against the Mycobacterium tuberculosis surrogate M. bovis bacille Calmette-Gu{\~A}{\textcopyright}rin.",

keywords = "infectious diseases, mycobacteria, tuberculosis",

author = "Khalil, {Zeinab G.} and Ritesh Raju and Piggott, {Andrew M.} and Salim, {Angela A.} and Antje Blumenthal and Capon, {Robert J.}",

year = "2015",

doi = "10.1021/acs.jnatprod.5b00095",

language = "English",

volume = "78",

pages = "949--952",

journal = "Journal of Natural Products",

issn = "0163-3864",

publisher = "American Chemical Society",

number = "4",

}

TY - JOUR

T1 - Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian marine-derived Streptomyces sp.

AU - Khalil, Zeinab G.

AU - Raju, Ritesh

AU - Piggott, Andrew M.

AU - Salim, Angela A.

AU - Blumenthal, Antje

AU - Capon, Robert J.

PY - 2015

Y1 - 2015

N2 - Chemical analysis of an Australian marine-derived Streptomyces sp. (CMB-M0150) yielded two new anthracycline antibiotics, aranciamycins I (1) and J (2), as well as the previously reported aranciamycin A (3) and aranciamycin (4). The aranciamycins 1-4, identified by detailed spectroscopic analysis, were noncytotoxic when tested against selected Gram-negative bacteria and fungi (IC50 >30 μM) and exhibited moderate and selective cytotoxicity against Gram-positive bacteria (IC50 >1.1 μM) and a panel of human cancer cell lines (IC50 > 7.5 μM). Significantly, 1-4 were cytotoxic (IC50 0.7-1.7 μM) against the Mycobacterium tuberculosis surrogate M. bovis bacille Calmette-GuÃ©rin.

AB - Chemical analysis of an Australian marine-derived Streptomyces sp. (CMB-M0150) yielded two new anthracycline antibiotics, aranciamycins I (1) and J (2), as well as the previously reported aranciamycin A (3) and aranciamycin (4). The aranciamycins 1-4, identified by detailed spectroscopic analysis, were noncytotoxic when tested against selected Gram-negative bacteria and fungi (IC50 >30 μM) and exhibited moderate and selective cytotoxicity against Gram-positive bacteria (IC50 >1.1 μM) and a panel of human cancer cell lines (IC50 > 7.5 μM). Significantly, 1-4 were cytotoxic (IC50 0.7-1.7 μM) against the Mycobacterium tuberculosis surrogate M. bovis bacille Calmette-GuÃ©rin.

KW - infectious diseases

KW - mycobacteria

KW - tuberculosis

UR - http://handle.uws.edu.au:8081/1959.7/uws:32736

U2 - 10.1021/acs.jnatprod.5b00095

DO - 10.1021/acs.jnatprod.5b00095

M3 - Article

SN - 0163-3864

VL - 78

SP - 949

EP - 952

JO - Journal of Natural Products

JF - Journal of Natural Products

IS - 4

ER -

Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian marine-derived Streptomyces sp.

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this